Optimi Health Corp. (FRA:8BN)

Market Cap	17.34M
Revenue (ttm)	342.25K
Net Income (ttm)	-2.55M
Shares Out	n/a
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.1630
Previous Close	0.1600
Day's Range	0.1630 - 0.1630
52-Week Range	0.0775 - 0.2340
Beta	n/a
RSI	32.84
Earnings Date	Jan 29, 2026

About Optimi Health

Optimi Health Corp. operates as a GMP-certified pharmaceutical drug manufacturing company in Canada. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of manufacturing of drug products. It sells its products through Amazon marketplace and distributors/brokers, as well as online. The company was formerly k...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2020
• Country: Canada
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8BN

Financial Performance

In 2024, Optimi Health's revenue was 389,850, an increase of 115.28% compared to the previous year's 181,087. Losses were -6.04 million, 16.2% more than in 2023.

Financial numbers in CAD